Recent

% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • fussyman2002 fussyman2002 May 16, 2012 7:06 PM Flag

    straight off the FDA site on lorqess hour ago

    PUBLIC SUBMISSION
    As of: 5/16/12 6:58 PM
    Tracking No. 80fe734a

    Docket: FDA-2012-P-0298
    Citizen Petition Concerning Obesity Medication Lorcaserin 10 mg BID and 10 mg QD

    Comment On: FDA-2012-P-0298-0001
    Joseph Dedvukaj Firm P.C. (On Behalf of Arena Pharmaceuticals, Inc. et al) - Citizen Petition

    Document: FDA-2012-P-0298-0005
    Donald P Galamaga MPA CCP DGCP - Comment
    Submitter Information
    Address:

    RI,
    Submitter's Representative: Donald P. Galamaga MPA CCP DGCP, Principal
    Organization: Organizations and Healthcare
    General Comment

    Lorqess, from my review of the information presented by Arena Pharmaceuticals, represents a safe and urgently needed medication to address the obesity crisis in the general populkation of the united States.
    The net weight loss results reported are effective across the age spectum and compare most favorably with those of Qnexa from VVUA Pharmaceuticals, with no negative comparable side effect profile.
    The prospect of Lorqess, thus, becoming a medication of first choice for physicians is , indeed very high, as is the prospect of patients adhering to approved medication regimens for long lasting effect.
    I therefore strongly recommend approval of Arena's Lorqess by the adviosory committee and the FDA at the forthing coming panel review session and FDA PDUFA date, if not sooner, without qualification

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ARNA
1.81-0.10(-5.24%)Jun 24 4:00 PMEDT